As reported by TechCrunch:
Boston biotech startup Ginkgo Bioworks has announced the raise of $275 million in Series D funding to build out its Bioworks3 production facility.
The funding comes from previous investors Viking Global, Y Combinator’s Continuity Fund, Cascade Investment, Bill Gates, as well as new investor, General Atlantic.
The company previously raised over $154 million, bringing the total up to $429 million in the three years since launching out of Y Combinator. The new raise now puts Ginkgo’s valuation at over $1 billion, according to sources... READ MORE